Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Discover the top features of no annual fee travel rewards cards. Choose the best option for your travel needs.
17,408 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Volatility can create buying opportunities. Here's one hypergrowth tech stock 2026 pick that blends AI momentum, scal...
A cliff-like Medicare IRMAA rule makes a tiny annual income step cost retirees hundreds more each month. This report ...
A fintech stock surged in recent years, then faced a pullback during down weeks. This article outlines a disciplined ...
Pfizer faced big headwinds after its Covid-era peak, but a longer horizon could open doors for outsized returns. Here...
A bold $1.5 billion investment signals Boston Scientific’s shift into transcatheter aortic valve replacement. Explore...
Global markets edge higher as AI spending sustains profits and optimism into the summer. Analysts say tech leadership...
A leading analyst signals more upside for CVS Health as Medicare-related momentum builds. Learn the key drivers, risk...
In a choppy market, one defense contractor shines as a rare dividend stock built for downturns. Its government-backed...
A crypto treasury firm AVAX faced Nasdaq scrutiny but bounced back after a strategic reverse split. This article brea...
Oracle’s shares have fallen sharply this year, leaving investors wondering if the decline creates a buying opportunit...
Crypto green! 6-9%! memes are driving momentum in today’s markets. This article breaks down the trend, profiles Pepe’...